000
| 01855cam 2200373zi 4500 |
---|
001 | 9.936485 |
---|
003 | CaOODSP |
---|
005 | 20240607103024 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 240408t20242024onc ob f000 0 eng d |
---|
020 | |a9780660712529|q(Statement) |
---|
020 | |a9780660712536|q(Summary) |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-362/1-2024E-PDF |
---|
086 | 1 |aHP40-362/2-2024E-PDF |
---|
245 | 00|aInterim guidance on the use of Imvamune in the context of a routine immunization program. |
---|
264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2024. |
---|
264 | 4|c©2024 |
---|
300 | |a1 online resource (29 pages) + |esummary (5 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aCover title. |
---|
500 | |aIssued also in French under title: Directives provisoires du CCNI sur l'utilisation d'Imvamune dans le cadre d'un programme de vaccination systématique. |
---|
500 | |aAt head of title: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). |
---|
500 | |aTitle appears with a registered symbol after the word “Imvamune”. |
---|
504 | |aIncludes bibliographical references. |
---|
650 | 0|aMpox (Disease)|xVaccination|zCanada. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
775 | 08|tDirectives provisoires du CCNI sur l'utilisation d'Imvamune dans le cadre d'un programme de vaccination systématique.|w(CaOODSP)9.936486 |
---|
856 | 40|qPDF|s814 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP40-362-1-2024-eng.pdf|z(Statement) |
---|
856 | 40|qPDF|s485 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP40-362-2-2024-eng.pdf|z(Summary) |
---|